IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 251 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,511,542 | +2.0% | 424,017 | +0.8% | 0.42% | +9.5% |
| Q1 2023 | $4,424,891 | -15.1% | 420,617 | 0.0% | 0.38% | -13.9% |
| Q4 2022 | $5,211,445 | +20.1% | 420,617 | +0.4% | 0.44% | +12.2% |
| Q3 2022 | $4,340,000 | +12.5% | 418,917 | +25.2% | 0.39% | +26.9% |
| Q2 2022 | $3,857,000 | -8.9% | 334,517 | -0.6% | 0.31% | +12.8% |
| Q1 2022 | $4,234,000 | +6.9% | 336,517 | -0.9% | 0.27% | +3.4% |
| Q4 2021 | $3,961,000 | -11.0% | 339,617 | -0.3% | 0.26% | -22.7% |
| Q3 2021 | $4,449,000 | +14.2% | 340,617 | +12.6% | 0.34% | +10.6% |
| Q2 2021 | $3,895,000 | +15.1% | 302,617 | 0.0% | 0.31% | +9.5% |
| Q1 2021 | $3,383,000 | +7254.3% | 302,617 | +6478.6% | 0.28% | +1786.7% |
| Q2 2013 | $46,000 | – | 4,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,855,515 | $43,661,000 | 13.90% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 772,369 | $11,810,000 | 7.13% |
| Rubric Capital Management LP | 1,275,000 | $19,495,000 | 6.70% |
| SECTOR GAMMA AS | 1,972,678 | $30,162,000 | 5.68% |
| BRIDGER MANAGEMENT, LLC | 1,879,313 | $28,735,000 | 2.00% |
| Asymmetry Capital Management, L.P. | 57,363 | $877,000 | 1.63% |
| Orbimed Advisors | 7,241,300 | $110,719,000 | 1.41% |
| Broderick Brian C | 144,476 | $2,209,000 | 0.96% |
| Granahan Investment Management | 1,408,000 | $21,528,000 | 0.74% |
| Spark Investment Management LLC | 499,200 | $7,632,000 | 0.63% |